ArticleBMC cancer2025
Dual-layer spectral detector CT quantitative parameters and radiomics for predicting spread through air spaces of lung adenocarcinoma: a dual-center study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesTo evaluate the value of quantitative parameters and radiomic features based on dual-layer spectral detector CT (DLCT) in predicting spread through air spaces (STAS) of lung adenocarcinoma (LUAD).
methodsThis study analyzed 266 patients with pathologically confirmed LUAD from two medical centers. Patients from center 1 were divided into training (n = 131) and internal validation (n = 57) sets, while center 2 (n = 78) formed the external validation set. Clinical data, conventional imaging features, and DLCT quantitative parameters were analyzed to develop a clinical-radiological model. Radiomic features were extracted from venous-phase images, including conventional images, virtual monoenergetic images (VMI) at 40 keV, 65 keV, and 100 keV, along with iodine density maps, effective atomic number (Zeff) maps, and electron density (ED) maps. The best-performing radiomics model was combined with clinical-radiological predictors to create a nomogram. Model performance was evaluated through ROC analysis, calibration curves, and decision curve analysis.
resultsMultivariate analysis revealed that tumor-lung interface and ED values were independent predictive factors in the clinical-radiological model. The optimal radiomics model was constructed based on VMI 40 keV, demonstrating AUCs of 0.899, 0.835, and 0.828 in the training, internal validation, and external validation sets, respectively. The nomogram, which incorporated the VMI 40 keV radiomics signature along with tumor-lung interface and ED values, outperformed the clinical-radiological model in the training set (AUC = 0.910 vs. 0.870; P = 0.018) and the internal validation set (AUC = 0.868 vs. 0.798; P = 0.046). While the improvement in the external validation set was not statistically significant (AUC = 0.848 vs. 0.819; P = 0.184).
conclusionThe nomogram, which integrates conventional imaging features, DLCT quantitative parameters and VMI 40 keV radiomic features, demonstrates promising performance and represents a potential valuable non-invasive tool for the preoperative assessment of STAS in LUAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.